WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Releases Updated NRDL and First Commercial Insurance Innovative Drug Lis... China announced on December 7 the release of an updated National Reimbursement Drug List (NRDL) and the country's first Commercial Insurance Innovative Drug List, marking...
(12/8/2025)

China Overhauls Drug Administration Rules, Emp... (2/10/2026)

China Biotech Lights Up. U.S. Stocks Prepare F... (2/10/2026)

Global Pharma in 2025: China Remains a Key Mar... (2/5/2026)

China Biotech Emerges as Global Deal Powerhous... (2/5/2026)

China's Innovation in Translational Medicine: ... (1/29/2026)

China's Labs Pull Ahead as Global Drugmakers I... (1/27/2026)

China's Early-Stage Drug Advantage Seen Persis... (1/27/2026)

China's Commercial Health Insurance Payouts fo... (1/23/2026)

China Emerges as Credible Challenger to US in ... (1/21/2026)

China Biopharma Innovation Takes Center Stage ... (1/17/2026)

China Biopharma Sees Record Financing and Lice... (1/13/2026)

China's 2025 Foreign Investment Catalogue Unlo... (1/13/2026)

Shiling Pharma Targets 2028 for Nasal Sp... (2/11/2026) China Eyes Approval for Russian Cancer V... (2/11/2026) GSK's RSV Vaccine Arexvy Moves Forward i... (2/11/2026) NHSA Issues Trial Measures for Early Com... (2/11/2026) AstraZeneca's China Business Hits New He... (2/10/2026) Weekly China Regulatory Roundup: EGFR, T... (2/10/2026) Insilico and CMS Partner on AI-Driven CN... (2/10/2026) Hengrui and Kailera Advance Obesity Ther... (2/10/2026) Cascade Raises $72M to Advance MASH, Obe... (2/10/2026) 3D Medicines Advances Envafolimab Toward... (2/10/2026) CDE Issues Technical Guideline for Gener... (2/9/2026) J&J Wins China Approval Expanding Subcut... (2/9/2026) InnoCare Wins China IND Clearance for VA... (2/9/2026) BioKangtai Cancels Planned Vaccine Joint... (2/9/2026) Roche and Henlius–Organon Resolve U.S. ... (2/9/2026) Ascletis Begins U.S. Phase II Trial of O... (2/9/2026) GenSci Advances Autoimmune Pipeline as N... (2/9/2026) Lilly Expands China Partnership With Inn... (2/9/2026)

China's Vaccine Exports Jump More Than 50% in 2025 as O... China's Vaccine Market Set for Slow but Steady Growth T... China Companion Animal Health Market to Reach US$ 3.7B ... China's Pet Obesity Sparks Biotech Race for Weight-Loss... China's Human Vaccine Market Set for Steady Long-Term E...

Cascade Raises $72M to Advance MASH, Obesity and Diabet... Hengrui and Kailera Advance Obesity Therapy After Encou... Insilico and CMS Partner on AI-Driven CNS and Autoimmun... AstraZeneca's China Business Hits New Heights as Record... Lilly Expands China Partnership With Innovent in New Gl...

CDE Issues Technical Guideline for Generic Sodium Iodid... CDE Issues Technical Guideline for Clinical Trials of C... CDE Issues Trial Guideline for Neuropathic Pain Drug De... 2026 National Conference on Drug Registration and Post-... China and USFDA Officials Pledge to Deepen Regulatory C...

NHSA Issues Trial Measures for Early Communication on R... China Moves to Accelerate New Healthcare Insurance Mode... China Launches Nationwide Crackdown on BMI Fraud in Men... China's Health Insurance Market Poised for $596B Surge ... Ant Group's AI Health Chatbot Surges in Popularity Amid...

Roche and Henlius–Organon Resolve U.S. Patent Dispute ... China Warns of Foreign Misuse of Research Ties to Acces... China's Supreme Court Upholds Semaglutide Patent, Stren... BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List...

Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk See... Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as... India and China Explore Reverse-Trade Model for Pharmac... Clariant Completes Expansion of Pharma Excipients and S...

GSK's RSV Vaccine Arexvy Moves Forward in China China Eyes Approval for Russian Cancer Vaccine 'Enterom... Shiling Pharma Targets 2028 for Nasal Spray Version of ... 3D Medicines Advances Envafolimab Toward Full Market Ap... Weekly China Regulatory Roundup: EGFR, TROP2 Approvals ...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...